Share：
Share this content in WeChat
X
[Chinese][PDF]811125
• Review •
Cardiac longitudinal relaxation time (T1) imaging technique and its clinical applications
RAN Ling-ping  XIA Li-ming 

DOI:10.12015/issn.1674-8034.2016.09.017.


[Abstract] T1 Mapping technique can obtain the myocardial T1 value quantitatively, and evaluate the myocardial histological features in various cardiomyopathy accurately. Many image acquisition technologies have been used to T1 Mapping sequences, and the native T1 which may reflect myocardial fibrosis has good reproducibility. It may detect diffuse myocardial injury by measuring native T1 value and post contrast T1 value. This review aims to introduce the T1 Mapping technique and its clinical applications.
[Keywords] Cardiac imaging techniques；Magnetic resonance imaging

RAN Ling-ping Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China

XIA Li-ming* Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China

*Correspondence to: Xia LM, E-mail: cjr.xialiming@vip.163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This work was supported by the general program of National Natural Science Foundation of China No. 81471637
Received  2016-06-20
Accepted  2016-08-16
DOI: 10.12015/issn.1674-8034.2016.09.017
DOI:10.12015/issn.1674-8034.2016.09.017.

[1]
Everett RJ, Stirrat CG, Semple SIR, et al. Assessment of myocardial fibrosis with T1 mapping MRI. Clin Radiol, 2016, 71(8): 768-778.
[2]
Messroghli DR, Radjenovic A, Kozerke S, et al. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med, 2004, 52(1): 141-146.
[3]
Messroghli DR, Greiser A, Frohlich M. Optimization and validation of a fully-integrated pulse sequencefor modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging, 2007, 26(4): 1081-1086.
[4]
Kellman P, Hansen MS. T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn R-eson, 2014, 16(1): 2.
[5]
Sussman MS, Yang IY, Fok KH, et al. Inversion group (IG) fitting: a new T mapping method for modified look-locker inversion recovery (MOLLI) that allows arbitrary inversion groupings and rest periods(including no rest period). Magn Reson Med, 2015, 75(6): 2332-2340.
[6]
Piechnik SK, Ferreira VM, Dall'Armellina E, et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson, 2010, 12(2): 69.
[7]
Roujol S, Weingartner S, Foppa M, et al. Accuracy, precision, and reproducibility of four T1 mappingsequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE. Radiology, 2014, 272(3): 683-689.
[8]
Chow K, Flewitt JA, Green JD, et al. Saturation recovery single-shot acquisition (SASHA) for myocardial T(1) mapping. Magn Reson Med, 2014, 71(16): 2082-2095.
[9]
Fernandes JL, Rochitte CE. T1 mapping: technique and applications. Magn Reson Imaging Clin N Am, 2015, 23(1): 25-34.
[10]
Mewton N, Liu CY, Croisille P. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol, 2011,57(8): 891-903.
[11]
Germain P, El Ghannudi S, Jeung MY, et al. Native T1 mapping of the heart - a pictorial review. Clin Med Insights Cardiol, 2014,8(Suppl 4): 1-11.
[12]
Park CH, Choi EY, Greiser A, et al. Diagnosis of acute global myocarditis using cardiac MRI with quantitative t1 and t2 mapping: case report and literature review. Korean J Radiol, 2013, 14(5): 727-732.
[13]
Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: A JACC white paper. J Am Coll Cardiol, 2009, 53(17): 1475-1487.
[14]
Ferreira VM, Piechnik SK, Dall'Armellina E, et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson, 2012, 14(1): 42.
[15]
Dall'Armellina E, Piechnik SK, Ferreira VM, et al. Cardiovascular magnetic resonance by non contrastT1-mapping allows assessment of severity of injury in acute myocardial infarction. J Cardiovasc Magn Reson, 2012, 15(6): 15.
[16]
Messroghli DR, Walters K, Plein S, et al. MyocardialT1 mapping: application to patients withacute and chronic myocardial infarction. Magn Reson Med, 2007, 58(1): 34-40.
[17]
Okur A, Kantarci M, Kizrak Y, et al. Quantitative evaluation of ischemic myocardial scar tissu-e by unenhanced T1 mapping using 3.0 Tesla MR scanner. Diagn Interv Radiol, 2014, 20(5): 407-413.
[18]
Banypersad SM, Moon JC, Whelan C. Updates in cardiac amyloidosis: a review. J Am Heart Assoc, 2012, 1: e 000364.
[19]
Karamitsos TD, Neubauer S. T1 mapping and amyloid cardiomyopathy: how much better can it get? Eur Heart J, 2015,36(4): 203-205.
[20]
Karamitsos TD, Piechnik SK, Banypersad SM, et al. Noncontrast T1 mapping for the diagnosis of car diac amyloidosis. JACC Cardiovasc Imaging, 2013, 6(4): 488-497.
[21]
Varnava AM, Elliott PM, Sharma S. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart, 2000, 84(5): 476-482.
[22]
Green JJ, Berger JS, Kramer CM. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc Imaging, 2012, 5(4): 370-377.
[23]
Lu M, Zhao S, Yin G, et al. T1 mapping for detection of left ventricular myocardial fibrosis in hypertrophic cardiomyopathy: a preliminary study. Eur J Radiol, 2013, 82(5): e225-231.
[24]
Dass S, Suttie JJ, Piechnik SK, et al. Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging, 2012, 5(6): 726-733.
[25]
Ellims AH, Iles LM, Ling LH, et al. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diast olicdysfunction. J Cardiovascular Magnetic Resonance, 2012, 14(3): 76.
[26]
Siepen FA, Buss SJ, Messroghli D, et al. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardi al biopsy. Eur Heart J Cardiovasc Imaging, 2015, 16(2): 210-216.
[27]
Puntmann VO, Voigt T, Chen Z, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging, 2013, 6(4): 475-484.
[28]
Mordi I, Carrick D, Bezerra H. T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation. Eur Heart J Cardiovasc Imaging, 2015, 17(7): 797-803.
[29]
Seydelmann N, Wanner C, Stork S. Fabry disease and the heart. Best Pract Res Clin Endocrin-ol Metab, 2015, 29(2): 195-204.
[30]
Sado DM, White SK, Piechnik SK, et al. Identification and assessment of Anderson-Fabry disease bycardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging, 2013, 6(3): 392-398.
[31]
Pica S, Sado DM, Maestrini V, et al. Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance. J Cardiovasc Magn Reson, 2014, 16(1): 99.
[32]
Soslow JH, Damon SM, Crum K, et al. Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy. J Cardiovasc Magn Reson, 2016, 18(1): 5.
[33]
Gao X, Liu M, Qu A, et al. Native magnetic resonance T1-mapping identifies diffuse myocar-dial injury in hypothyroidism. PLoS One, 2016, 11: e0151266.
[34]
Ng AC, Auger D, Delgado V, et al. Association between diffuse myocardial fibrosis by cardi-ac magnetic resonance contrast-enhanced T1 mapping and subclinical myocardial dysfunction in diabetic patients a pilot study. Circ Cardiovasc Imaging, 2012, 5(1): 51-59.

PREV The advanced imaging of IDH-1 mutation in gliomas
NEXT Evaluation of the morphological characteristics and infarction pattern of unilateral middle cerebral artery occlusion using high resolution magnetic resonance imaging
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn